Evidence supporting the use of: Vitamin E
For the health condition: Radiation Sickness

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E has been investigated as a potential mitigator of radiation sickness due to its antioxidant properties. Radiation exposure generates reactive oxygen species (ROS) that damage cellular components, including DNA, proteins, and lipids, leading to the clinical manifestations of radiation sickness. Vitamin E, particularly in its alpha-tocopherol form, is a fat-soluble antioxidant that can help neutralize ROS and limit oxidative damage.

Preclinical studies in animals have shown that vitamin E supplementation can reduce some of the acute and chronic effects of radiation exposure, such as hematopoietic (blood cell) and gastrointestinal damage. Some studies have demonstrated improved survival rates and reduced tissue injury when vitamin E or its analogs were administered before or after radiation exposure.

However, robust clinical evidence in humans is lacking. Most data come from laboratory and animal studies, and there are few well-designed human trials to confirm efficacy or establish optimal dosing protocols. The U.S. FDA has not approved vitamin E for the treatment or prevention of radiation sickness. In summary, while the use of vitamin E is based on plausible biological mechanisms and supported by animal research, the current level of scientific evidence in humans remains limited, meriting a moderate evidence rating.

More about vitamin E
More about Radiation Sickness